These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4038567)

  • 1. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):209-17. PubMed ID: 4039234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly.
    Wass JA; Clemmons DR; Underwood LE; Barrow I; Besser GM; Van Wyk JJ
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):369-77. PubMed ID: 6890417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
    Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
    J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive GH-like immunoglobulins G in active acromegaly: response to long-term treatment with bromocriptine.
    Campino C; Szecowka J; Lopez JM; Seron-Ferre M
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):111-6. PubMed ID: 7641402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly.
    Barreca A; Ciccarelli E; Minuto F; Bruzzi P; Giordano G; Camanni F
    Acta Endocrinol (Copenh); 1989 May; 120(5):629-35. PubMed ID: 2728807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995).
    Lamberts SW; Uitterlinden P; Verleun T
    Eur J Clin Invest; 1987 Aug; 17(4):354-9. PubMed ID: 2889603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of bromocriptine treatment for acromegaly.
    Maneschi F
    Horm Res; 1980; 12(4):191-205. PubMed ID: 7390405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A; Doga M; Bussi AR; Licini M; Schettino M
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response.
    Stonesifer LD; Jordan RM; Kohler PO
    J Clin Endocrinol Metab; 1981 Nov; 53(5):931-4. PubMed ID: 7197287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
    Barkan AL; Beitins IZ; Kelch RP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.